Close Menu
  • Home
  • Vaccines
  • Politics
  • Health
  • Tech
  • Sports
  • Research
  • Fitness
  • Careers
What's Hot

Health Canada approves Novartis’ KISQALI® for HR+/HER2- early breast cancer patients at high risk of recurrence

Sheriff, county lawyer seeking mental health funds at Minnesota State Capitol

Chronic absences have not disappeared. Research shows that poor children are most hurt.

Facebook X (Twitter) Instagram
subjectional.com
Subscribe
  • Home
  • Vaccines
  • Politics
  • Health
  • Tech
  • Sports
  • Research
  • Fitness
  • Careers
subjectional.com
Home » IFF Pharma Solutions presents groundbreaking research at AAPS 2024 PharmSci 360
Research

IFF Pharma Solutions presents groundbreaking research at AAPS 2024 PharmSci 360

Paul E.By Paul E.October 15, 2024No Comments4 Mins Read
Share Facebook Twitter Pinterest Copy Link Telegram LinkedIn Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email


Attendees will explore the pivotal role of excipients in drug delivery and gain unique insight.

NEW YORK, Oct. 14, 2024 /PRNewswire/ — IFF (NYSE:IFF) Pharma Solutions will present groundbreaking research at AAPS 2024 PharmSci 360 on October 20 in Salt Lake City, Utah This demonstrates the important role of excipients in formulation. IFF Pharma Solutions’ scientific posters and presentations cover nitrosamine risk mitigation, controlled release performance, extrusion spheronization and pellet quality, softgel stability, and excipient selection for plant-based drug formulations. Uncover important advances. Gummy.

Paula García Todd, Global Application Development and Innovation Leader, IFF Pharma Solutions. “By leveraging our deep expertise in polymers and excipients, we are helping pharmaceutical manufacturers develop safer and more effective formulations and remain at the forefront of an ever-evolving industry. Masu.”

Introducing technology backed by science

IFF experts will demonstrate how excipients can support safe drug formulation and manufacturing, and present new research on nitrosamine production kinetics in upcoming sessions.

Tuesday, Oct. 22, 10:30-11:30 a.m. Mountain Time (Montana) – Two scientific posters provide new insights into quick-acting solutions. Applications Senior Principal Scientist Yeli Zhang Ph.D. will present “Selection of Microcrystalline Cellulose-Based Excipients in Extrusion Spheronization.” Principal Investigator Jin Zhao Ph.D, in his poster “Vegetarian Softgels Using SeaGel® Technology for Pharmaceutical Applications,” demonstrated the superiority of plant-based capsules in heat resistance and stability compared to gelatin capsules under various aging conditions. Introducing the excellent performance of soft gel.

Tuesday, October 22nd, 12:30pm – 1:30pm (Montana Time) – Dr. Nasrin Mahmoudi, Senior Principal Application Scientist, will speak on “Low Nitrite Controlled Release Formulation of Water-Soluble Drugs” and discuss safety and We will introduce the development of safe formulations. Robust controlled-release matrix tablet formulations for active pharmaceutical ingredients (APIs) containing fragile amines.

Wednesday, October 23, 10:30-11:30 a.m. MT in the 360 ​​Stage #3 Exhibit Hall – Koudi Zhu, Senior Analytical Scientist, will be presenting the highly sensitive two-dimensional ion chromatography mass spectrometry (2D-IC) /MS) method. Awarded for his presentation “Advances in analytical methods for the determination of nitrite in pharmaceutical excipients” for the detection of trace amounts of nitrite in hydroxypropyl methylcellulose (HPMC).

Wednesday, October 23, 11:30 a.m. – 12:30 p.m. (Montana Time) – Mark Dreibelbis Ph.D., Senior Research and Development Scientist, presents a matrix table of hydrophilic polymers predicting their controlled release performance. We will share the results of investigating the characteristics. Prediction of performance of hydroxypropyl methylcellulose controlled release matrix by powder dissolution temperature. ”

Audiences attending the poster session will receive exclusive information on how different carrageenan grades affect the properties of pharmaceutical gummy formulations, as well as the role of lubricant components in enhancing the stability of pectin coatings on tablets. You can expect some insight.

Monday, October 21, 2:30pm MT – “Formulation and in vitro evaluation of carrageenan-based gummies” by Dr. Nasrin Mahmoudi.

Wednesday, October 23, 12:30 PM (Montana) – “The Effects of Lubricants on Functional Tablet Coatings Containing Pectin” by Dr. Becca Putans, Principal Scientist.

For more information, book a meeting with the IFF Pharma Solutions team here at booth #2705 or visit our Knowledge Hub to view IFF’s original research and the latest scientific posters.

Welcome to IFF

IFF (NYSE:IFF) brings together food, beverage, health, bioscience and fragrance industry leaders, science and creativity to create essential solutions for a better world, from global icons to unexpected innovations and experiences. is produced. We are a collection of international thinkers who, with the beauty of art and the precision of science, partner with our customers to deliver the product scents, tastes, experiences, ingredients and solutions the world demands. Together, we can do even better for people and the planet. For more information, visit iff.com, X (Twitter), Facebook, Instagram, LinkedIn.

©2024 International Flavors & Fragrances Inc. (IFF). IFF, the IFF logo, and all trademarks and service marks identified as TM, SM, and ® are owned by IFF or IFF affiliates, unless otherwise noted. Unauthorized reproduction is prohibited.

contact:

Emily Kaufman

Global Communication Specialist

+1 908-670-5691

emily.kaufman@iff.com

Source IFF





Source link

Follow on Google News Follow on Flipboard
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Copy Link
Previous ArticleMost of UC’s non-football sports will join the Mountain West.
Next Article State, Public Health, Dairy Farm Confirms 6 Cases of Bird Flu, Aims to Protect Employees
Paul E.
  • Website

Related Posts

Chronic absences have not disappeared. Research shows that poor children are most hurt.

June 5, 2025

American Brain Tumor Society’s Metastatic Brain Tumor Collaborative Announces $50,000 Research Grant Opportunity to Fund High-Risk, High-Impact CNS Metastasis Research

October 31, 2024

Massive yard sale in Newtown benefits pancreatic cancer research

October 31, 2024
Leave A Reply Cancel Reply

Latest Posts

Health Canada approves Novartis’ KISQALI® for HR+/HER2- early breast cancer patients at high risk of recurrence

Sheriff, county lawyer seeking mental health funds at Minnesota State Capitol

Chronic absences have not disappeared. Research shows that poor children are most hurt.

Transport Secretary reveals overhaul of aging pneumatic transport systems

Latest Posts

Subscribe to News

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

Welcome to Subjectional!

At Subjectional, we believe that informed opinions are the foundation of a vibrant society. Our mission is to provide insightful, engaging, and balanced information across a diverse range of topics that matter to you. Whether you’re interested in the latest developments in health, navigating the complexities of politics, staying updated on sports, exploring technological advancements, or advancing your career, we’ve got you covered.

Facebook X (Twitter) Instagram Pinterest YouTube

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

Facebook X (Twitter) Instagram Pinterest
  • Home
  • About Us
  • Advertise with Us
  • Contact us
  • DMCA
  • Privacy Policy
  • Terms & Conditions
© 2025 subjectional. Designed by subjectional.

Type above and press Enter to search. Press Esc to cancel.